Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/1996
11/28/1996WO1996037488A1 Piperazine derivatives
11/28/1996WO1996037203A1 Method to increase retinal blood flow
11/28/1996WO1996037200A1 Use of dha as a pharmaceutical composition
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2195979A1 Use of dha as a pharmaceutical composition
11/27/1996EP0743852A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578618 Treatment of vision defects
11/26/1996US5578612 Indole derivatives
11/26/1996US5578610 Piperidine derivatives
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036599A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
11/21/1996WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996WO1996036334A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
11/21/1996CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/20/1996EP0531529B1 Process for preparing aqueous suspension
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/19/1996US5576437 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
11/19/1996US5576345 Method and means for inhibiting posterior capsule opacification
11/19/1996US5576330 Mixture of an angiogenesis inhibitor and an antitumor agent
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035448A1 Preventive for postoperative astigmatism
11/14/1996WO1996035424A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220517A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2219973A1 Peptidyl compounds and their therapeutic use
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/13/1996EP0741709A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741563A1 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
11/12/1996US5573758 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740668A1 Tetracyclic derivatives, process of preparation and use
11/06/1996EP0740655A1 Metalloproteinase inhibitors
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0740652A1 Metalloproteinase inhibitors
11/06/1996EP0740649A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
11/06/1996EP0740550A1 Use of mometasone furoate for treating airway passage and lung diseases
11/06/1996EP0740549A1 Cis-hydroxyproline analogs for eye treatment
11/05/1996US5571826 Heterocyclic compounds and their preparation and use
11/05/1996US5571823 Pharmacological treatment of ocular development
11/05/1996US5571813 Treatment of hypertension, congestive heart failure, renal failure
10/1996
10/31/1996WO1996034010A2 Inhibitors of farnesyl-protein transferase
10/31/1996WO1996033719A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
10/31/1996WO1996033678A1 Triacetin as a transdermal penetration enhancer
10/30/1996EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists
10/30/1996EP0512071B1 Method and compositions for inhibiting angiogenesis
10/30/1996CN1134699A Succinamic acid compound, process for producing the same, and use thereof
10/29/1996US5569768 Angiotensin II antagonists
10/29/1996US5569593 Inducing root formation from pilocarpus genus plant
10/24/1996WO1996033166A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors
10/24/1996WO1996033165A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
10/24/1996WO1996033161A1 Derivatives of succinamide and their use as metalloproteinase inhibitors
10/24/1996WO1996032951A1 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/24/1996WO1996032941A1 Pranoprofen eyedrops containing organic amine
10/24/1996WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists
10/24/1996CA2218380A1 Novel hydroxamic and carbocylic acids as metalloprotease inhibitors
10/23/1996EP0738727A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
10/23/1996EP0738270A1 Dihydro pyrazolopyrroles
10/23/1996CN1134153A Matrix metalloprotease inhibitors
10/22/1996US5567731 Gaba-ergic modulation of eye growth
10/22/1996US5567721 Aromatic urea compound for skin disorder, rheumatic disease, respiratory disorder and eye disorder
10/22/1996US5567417 Method for inhibiting angiogenesis using heparinase
10/17/1996WO1996032386A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/17/1996WO1996032385A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
10/17/1996WO1996032384A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/17/1996WO1996032379A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
10/17/1996WO1996032108A1 Treatment for ocular inflammation
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996CA2217707A1 Indole derivatives as cgmp-pde inhibitors
10/17/1996CA2217599A1 Treatment for ocular inflammation
10/16/1996EP0737676A1 Prostaglandin derivative, salt thereof, and use thereof
10/16/1996EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
10/16/1996EP0737199A1 Method for preparing concentrated biologically active silicon compounds
10/16/1996EP0737196A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
10/16/1996EP0737185A1 7- carboxyalkyl or alkenyl]-6- alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo- 3.2.1] octane and derivatives thereof
10/16/1996EP0737184A1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996CN1133296A 11 beta-aromatic group-4-estraene and acid additive salt application in medicine
10/15/1996US5565480 Substituted histidines
10/15/1996US5565470 Cycloaminoalkoxyphenyl derivatives, a process for their preparation as well as the compositions containing them
10/15/1996US5565464 Compounds having angiotensine II antagonistic activity
10/15/1996US5565345 Reduction by the action of a microorganism
10/15/1996CA2042972C Treatment of ocular hypertension with a synergistic combination for ocular administration
1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 531